B. Kuru Et Al. , "Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy," DIAGNOSTIC CYTOPATHOLOGY , vol.44, no.5, pp.394-398, 2016
Kuru, B. Et Al. 2016. Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy. DIAGNOSTIC CYTOPATHOLOGY , vol.44, no.5 , 394-398.
Kuru, B., Atmaca, A., & Kefeli, M., (2016). Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy. DIAGNOSTIC CYTOPATHOLOGY , vol.44, no.5, 394-398.
Kuru, Bekir, Ayşegül Atmaca, And Mehmet Kefeli. "Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy," DIAGNOSTIC CYTOPATHOLOGY , vol.44, no.5, 394-398, 2016
Kuru, Bekir Et Al. "Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy." DIAGNOSTIC CYTOPATHOLOGY , vol.44, no.5, pp.394-398, 2016
Kuru, B. Atmaca, A. And Kefeli, M. (2016) . "Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy." DIAGNOSTIC CYTOPATHOLOGY , vol.44, no.5, pp.394-398.
@article{article, author={Bekir Kuru Et Al. }, title={Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy}, journal={DIAGNOSTIC CYTOPATHOLOGY}, year=2016, pages={394-398} }